1. Home
  2. SOLV vs PSO Comparison

SOLV vs PSO Comparison

Compare SOLV & PSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOLV
  • PSO
  • Stock Information
  • Founded
  • SOLV 2023
  • PSO 1844
  • Country
  • SOLV United States
  • PSO United Kingdom
  • Employees
  • SOLV N/A
  • PSO N/A
  • Industry
  • SOLV
  • PSO Books
  • Sector
  • SOLV
  • PSO Consumer Discretionary
  • Exchange
  • SOLV NYSE
  • PSO Nasdaq
  • Market Cap
  • SOLV 11.1B
  • PSO 9.0B
  • IPO Year
  • SOLV N/A
  • PSO 2000
  • Fundamental
  • Price
  • SOLV $67.02
  • PSO $13.81
  • Analyst Decision
  • SOLV Hold
  • PSO
  • Analyst Count
  • SOLV 5
  • PSO 0
  • Target Price
  • SOLV $58.25
  • PSO N/A
  • AVG Volume (30 Days)
  • SOLV 1.1M
  • PSO 243.8K
  • Earning Date
  • SOLV 08-08-2024
  • PSO 01-01-0001
  • Dividend Yield
  • SOLV N/A
  • PSO 2.11%
  • EPS Growth
  • SOLV N/A
  • PSO 23.43
  • EPS
  • SOLV 6.12
  • PSO 0.63
  • Revenue
  • SOLV $8,207,000,000.00
  • PSO $4,485,194,688.00
  • Revenue This Year
  • SOLV $2.00
  • PSO N/A
  • Revenue Next Year
  • SOLV $0.05
  • PSO $4.08
  • P/E Ratio
  • SOLV $10.95
  • PSO $21.25
  • Revenue Growth
  • SOLV 1.31
  • PSO N/A
  • 52 Week Low
  • SOLV $47.16
  • PSO $10.31
  • 52 Week High
  • SOLV $72.40
  • PSO $14.20
  • Technical
  • Relative Strength Index (RSI)
  • SOLV N/A
  • PSO 59.48
  • Support Level
  • SOLV N/A
  • PSO $13.87
  • Resistance Level
  • SOLV N/A
  • PSO $14.20
  • Average True Range (ATR)
  • SOLV 0.00
  • PSO 0.11
  • MACD
  • SOLV 0.00
  • PSO 0.01
  • Stochastic Oscillator
  • SOLV 0.00
  • PSO 50.63

About SOLV SOLVENTUM CORP

Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.

About PSO Pearson Plc

U.K.-listed Pearson is the world's largest educational provider. The company has been disposing of noncore businesses such as the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider. While Pearson's primary activity centres on higher-level education, the firm also has significant operations in providing clinical assessments, professional certification and testing.

Share on Social Networks: